Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial.
Saved in:
| Title: | Role of pMAPkinase, pAKT, p27 & IGF-IR as predictive markers of response to trastuzumab in patients with HER2-positive invasive breast cancer treated with neoadjuvant chemotherapy + trastuzumab in the REMAGUS02 trial. |
|---|---|
| Authors: | Mathieu, M. C., Goubar, A., Sigal, B., Bertheau, P., Guinebretière, J. M., André, F., Pierga, J. Y., Delaloge, S., Giacchetti, S., Brain, E., Marty, M. |
| Source: | Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p877-878. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
